Phospholipids (PL) (PL)

Phospholipids are the fundamental building blocks of all cellular membranes, organized into a semi-permeable lipid bilayer that defines cellular boundaries and organelle compartments (StatPearls, NBK534804). Beyond their structural role, they serve as essential precursors for signaling molecules, such as arachidonic acid and phosphoinositides, which regulate cell growth, survival, and inflammatory responses (Nature Reviews Drug Discovery, 2007). In various pathologies, the distribution and composition of phospholipids are significantly altered; for instance, the externalization of phosphatidylserine is a hallmark of apoptosis and is exploited in cancer imaging and therapy (Journal of Controlled Release, 2014). Therapeutic strategies targeting phospholipids include antimicrobial agents like Polymyxin B and Daptomycin that disrupt bacterial membranes, and monoclonal antibodies like Bavituximab designed to recognize specific lipid signatures in the tumor microenvironment (Frontiers in Pharmacology, 2020). These molecules are also critical in respiratory health, where pulmonary surfactants (primarily phospholipids) prevent alveolar collapse (StatPearls, NBK534804). Drugs targeting these lipids often rely on the differences in lipid composition between host and pathogen cells to achieve selectivity. However, the ubiquitous nature of phospholipids presents significant challenges in avoiding off-target effects in human tissues. Overall, phospholipids represent a diverse class of targets with applications ranging from infectious disease to oncology and regenerative medicine.

Other names

Membrane phospholipidsGlycerophospholipidsPhosphoglyceridesCell membrane lipids

Direct binding to membrane phospholipids leading to membrane permeabilization, pore formation, or disruption of lipid signaling pathways (Nature Reviews Drug Discovery, 2007; Frontiers in Pharmacology, 2020).